DOTA-NOC acetate
Precursor for radiolabelled DOTA-NOC
DOTA-[Nal3]-octreotide; CA index name: L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)- L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide
Sequence: DOTA-D-Phe-Cys-1Nal-D-Trp-Lys-Thr-Cys-Thr(ol), cyclic disulfide Cys2,7; DOTA = N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-; Nal = 3-(1-naphthalenyl )-L-alanyl; Supplied as acetate salt
Qualität
Research Chemical
Eigenschaften
Molare Masse 1455.7
CAS RN [619300-53-7] (net peptide)
Reinheit ≥ 95 %
- Colorless to off-white freeze-dried solid
Zertifikate
CoA: appearance, MS (identity), HPLC (purity)
Literatur
Wild D. et al. ⁶⁸Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5. Eur.J. Nucl. Med. Mol. Imaging 2005, 32, 724.
Wild D. et al. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labeling with various radiometals. Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 1338–1347.
Zur Anfrage hinzufügen
Produkt | Produktnummer | Füllmenge | Anzahl | ||
---|---|---|---|---|---|
/de/Produkte/Kleine-Molekuele-und-Peptide/chemical/2de35bbf-c6db-49ca-9691-0c66094f5cc5 | Precursor | Produktnummer: 9712 | Füllmenge: 1 mg | ||
/de/Produkte/Kleine-Molekuele-und-Peptide/chemical/2de35bbf-c6db-49ca-9691-0c66094f5cc5 | Precursor | Produktnummer: 9712 | Füllmenge: 10 mg | ||
/de/Produkte/Kleine-Molekuele-und-Peptide/chemical/2de35bbf-c6db-49ca-9691-0c66094f5cc5 | Precursor | Produktnummer: 9712 |